Side-by-side comparison of AI visibility scores, market position, and capabilities
AcuityMD is the MedTech commercial intelligence platform trusted by nearly 500 companies including 8 of the top 10; raised $163M total including an $80M Series C; named to Forbes' 2025 Next Billion-Dollar Startups list;
AcuityMD is a Boston-based software company founded in 2018 that builds AI-powered commercial intelligence tools specifically for the medical technology (MedTech) industry. The platform provides medical device sales teams with a unified view of market data, physician and facility targeting, claims analytics, and CRM-integrated workflows — enabling them to identify the highest-value opportunities, forecast sales performance, and prioritize outreach with AI-generated next-best actions. AcuityMD draws on a dataset encompassing more than 330 million patients from an all-payor claims dataset built in partnership with CMS and major claims aggregators.
mRNA pioneer with $3.2B FY2024 revenue (down from $18.4B 2022 COVID peak); mRESVIA RSV vaccine approved 2024; personalized cancer vaccine with Merck shows 44% recurrence reduction in melanoma.
Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stéphane Bancel, and others in Cambridge, Massachusetts, where it is headquartered and trades on Nasdaq (MRNA). The company achieved extraordinary commercial success with Spikevax, its COVID-19 mRNA vaccine developed in partnership with the U.S. government in 2020—generating $18.4 billion in COVID vaccine revenues in 2022 at peak—before experiencing a severe revenue decline as global COVID booster demand normalized. For FY2024, Moderna generated approximately $3.2 billion in revenues, with Spikevax and the reformulated XBB.1.5-targeting COVID vaccine contributing the majority, while the company's significant R&D investment pipeline consumed most operating cash flows.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.